If you purchased GSK ADRs during the Class Period you may be entitled to compensation without payment of any out of pocket ...

NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

GSK PLC closed 16.86% short of its 52-week high of £18.24, which the company reached on May 16th.

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

GSK PLC closed 15.88% below its 52-week high of £18.24, which the company reached on May 16th.

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best weight loss drug stocks to buy according to analysts. Most people have tried to include fitness ...

GSK plc (NYSE:GSK) specializes in pharmaceuticals, vaccines, and consumer health products, with a strong focus on immunology.

Shares of GSK plc (LON:GSK – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports.

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us. Follow us ...

GSK Stock Performance GSK opened at $40.08 on Friday. The firm has a market cap of $83.07 billion, a P/E ratio of 25.21, a price-to-earnings-growth ratio of 1.12 and a beta of 0.58. GSK plc has a ...

NEW YORK, March 6, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period ...